Published in Intensive Care Med on November 14, 2007
Corticosteroids in the prevention and treatment of acute respiratory distress syndrome (ARDS) in adults: meta-analysis. BMJ (2008) 1.75
Corticosteroids in the treatment of community-acquired pneumonia in adults: a meta-analysis. PLoS One (2012) 1.09
Acute respiratory distress syndrome: pathophysiology and therapeutic options. J Clin Med Res (2012) 1.01
Steroids for acute respiratory distress syndrome? Clin Chest Med (2014) 0.93
Mesenchymal stem cells - a promising therapy for Acute Respiratory Distress Syndrome. F1000 Med Rep (2012) 0.93
Guidelines on management of human infection with the novel virus influenza A (H1N1)--a report from the Hospital das Clínicas of the University of São Paulo. Clinics (Sao Paulo) (2009) 0.90
The acute respiratory distress syndrome. Proc (Bayl Univ Med Cent) (2015) 0.90
Update on adrenal insufficiency in patients with liver cirrhosis. World J Gastroenterol (2013) 0.89
Mechanical ventilation-associated lung fibrosis in acute respiratory distress syndrome: a significant contributor to poor outcome. Anesthesiology (2014) 0.85
Comparison of reducing effect on lung injury of dexamethasone and bosentan in acute lung injury: an experimental study. Multidiscip Respir Med (2013) 0.84
The influence of prehospital systemic corticosteroid use on development of acute respiratory distress syndrome and hospital outcomes. Crit Care Med (2013) 0.83
The pharmacology of acute lung injury in sepsis. Adv Pharmacol Sci (2011) 0.82
Key mechanisms governing resolution of lung inflammation. Semin Immunopathol (2016) 0.81
Dexamethasone attenuates VEGF expression and inflammation but not barrier dysfunction in a murine model of ventilator-induced lung injury. PLoS One (2013) 0.81
Corticosteroid therapy in acute respiratory distress syndrome. CMAJ (2012) 0.80
Nasal potential difference to detect Na+ channel dysfunction in acute lung injury. Am J Physiol Lung Cell Mol Physiol (2010) 0.77
Rationale for Prolonged Glucocorticoid Use in Pediatric ARDS: What the Adults Can Teach Us. Front Pediatr (2016) 0.77
Corticosteroids and ARDS: A review of treatment and prevention evidence. Lung India (2011) 0.77
Regulation of inflammatory biomarkers by intravenous methylprednisolone in pediatric ARDS patients: Results from a double-blind, placebo-controlled randomized pilot trial. Cytokine (2015) 0.77
Inhibition of endogenous glucocorticoid synthesis aggravates lung injury triggered by septic shock in rats. Int J Exp Pathol (2015) 0.76
Year in review in Intensive Care Medicine, 2008: II. Experimental, acute respiratory failure and ARDS, mechanical ventilation and endotracheal intubation. Intensive Care Med (2009) 0.75
Coupled plasma filtration adsorption for the treatment of a patient with acute respiratory distress syndrome and acute kidney injury: a case report. NDT Plus (2011) 0.75
The effects of dexamethasone and oxygen in ventilated adult sheep with early phase acute respiratory distress syndrome. Lung (2014) 0.75
Plasma Biomarker Analysis in Pediatric ARDS: Generating Future Framework from a Pilot Randomized Control Trial of Methylprednisolone: A Framework for Identifying Plasma Biomarkers Related to Clinical Outcomes in Pediatric ARDS. Front Pediatr (2016) 0.75
Prolonged Glucocorticoid Treatment in ARDS: Impact on Intensive Care Unit-Acquired Weakness. Front Pediatr (2016) 0.75
Dexamethasone inhibits endotoxin-induced coagulopathy in human lungs. J Thromb Haemost (2016) 0.75
The efficacy of systemic corticosteroids in treatment of respiratory tract infections during hajj 2012. Iran Red Crescent Med J (2015) 0.75
A Critical Care and Transplantation-Based Approach to Acute Respiratory Failure after Hematopoietic Stem Cell Transplantation in Children. Biol Blood Marrow Transplant (2015) 0.75
Clinical Practice Guideline of Acute Respiratory Distress Syndrome. Tuberc Respir Dis (Seoul) (2016) 0.75
Efficacy of prone position in acute respiratory distress syndrome patients: A pathophysiology-based review. World J Crit Care Med (2016) 0.75
Effective and Safe Use of Glucocorticosteroids for Rescue of Late ARDS. Case Rep Crit Care (2017) 0.75
The clinical practice guideline for the management of ARDS in Japan. J Intensive Care (2017) 0.75
Use of corticosteroids in acute respiratory distress syndrome: Perspective from an Indian intensive care unit. Med J Armed Forces India (2016) 0.75
Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. The Acute Respiratory Distress Syndrome Network. N Engl J Med (2000) 48.03
Incidence and outcomes of acute lung injury. N Engl J Med (2005) 21.56
Comparison of two fluid-management strategies in acute lung injury. N Engl J Med (2006) 19.54
Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock. JAMA (2002) 16.37
One-year outcomes in survivors of the acute respiratory distress syndrome. N Engl J Med (2003) 11.77
Efficacy and safety of corticosteroids for persistent acute respiratory distress syndrome. N Engl J Med (2006) 9.52
Methylprednisolone infusion in early severe ARDS: results of a randomized controlled trial. Chest (2007) 7.49
Lower tidal volume ventilation and plasma cytokine markers of inflammation in patients with acute lung injury. Crit Care Med (2005) 5.76
Hydrocortisone infusion for severe community-acquired pneumonia: a preliminary randomized study. Am J Respir Crit Care Med (2004) 4.58
Effect of prolonged methylprednisolone therapy in unresolving acute respiratory distress syndrome: a randomized controlled trial. JAMA (1998) 4.21
Corticosteroid treatment for sepsis: a critical appraisal and meta-analysis of the literature. Crit Care Med (1995) 3.74
Effect of low doses of corticosteroids in septic shock patients with or without early acute respiratory distress syndrome. Crit Care Med (2006) 2.69
Immunologic and hemodynamic effects of "low-dose" hydrocortisone in septic shock: a double-blind, randomized, placebo-controlled, crossover study. Am J Respir Crit Care Med (2002) 2.52
Does ICU-acquired paresis lengthen weaning from mechanical ventilation? Intensive Care Med (2004) 2.35
High-dose corticosteroids in patients with the adult respiratory distress syndrome. N Engl J Med (1987) 2.32
Prolonged methylprednisolone treatment suppresses systemic inflammation in patients with unresolving acute respiratory distress syndrome: evidence for inadequate endogenous glucocorticoid secretion and inflammation-induced immune cell resistance to glucocorticoids. Am J Respir Crit Care Med (2002) 1.52
Established ARDS treated with a sustained course of adrenocortical steroids. Chest (1990) 1.50
Corticosteroids in acute respiratory failure. Am J Respir Crit Care Med (1999) 1.42
Etiology and outcomes of pulmonary and extrapulmonary acute lung injury/ARDS in a respiratory ICU in North India. Chest (2006) 1.33
Procollagen types I and III aminoterminal propeptide levels during acute respiratory distress syndrome and in response to methylprednisolone treatment. Am J Respir Crit Care Med (1998) 1.23
Acute respiratory distress syndrome in the trauma intensive care unit: Morbid but not mortal. Arch Surg (2006) 1.09
Muscle weakness in mechanically ventilated patients with severe asthma. Am J Respir Crit Care Med (1996) 1.07
Predictors of mortality in ARDS patients referred to a tertiary care centre: a pilot study. Eur J Anaesthesiol (2006) 0.99
Ozone-induced acute pulmonary fibrosis in rats. Prevention of increased rates of collagen synthesis by methylprednisolone. Am Rev Respir Dis (1981) 0.97
Systemic inflammation-associated glucocorticoid resistance and outcome of ARDS. Ann N Y Acad Sci (2004) 0.96
Prospective validation of an acute respiratory distress syndrome predictive score. Am J Respir Crit Care Med (1995) 0.93
Immunomodulation in septic shock: hydrocortisone differentially regulates cytokine responses. J Am Soc Nephrol (2001) 0.91
Systematic review of determinants of mortality in high frequency oscillatory ventilation in acute respiratory distress syndrome. Crit Care (2006) 0.87
Nuclear factor-kappaB- and glucocorticoid receptor alpha- mediated mechanisms in the regulation of systemic and pulmonary inflammation during sepsis and acute respiratory distress syndrome. Evidence for inflammation-induced target tissue resistance to glucocorticoids. Neuroimmunomodulation (2005) 0.87
Idiopathic pulmonary fibrosis in adult respiratory distress syndrome. Diagnosis and treatment. Arch Surg (1985) 0.86
[Cohort study on incidence of ARDS in patients admitted to the ICU and prognostic factors of mortality]. Med Intensiva (2006) 0.86
Time-variant increase in methylprednisolone clearance in patients with acute respiratory distress syndrome: a population pharmacokinetic study. J Clin Pharmacol (2001) 0.85
Host defense response and outcome in ARDS. Chest (1997) 0.83
Influence of hypercortisolemia on soluble tumor necrosis factor receptor II and interleukin-1 receptor antagonist responses to endotoxin in human beings. Surgery (1995) 0.83
Methylprednisolone for unresolving ARDS. JAMA (1999) 0.77
Potentiation of butylated-hydroxytoluene-induced acute lung damage by oxygen. Effects of prednisolone and indomethacin. Am Rev Respir Dis (1983) 0.77
An in vitro study of how much methylprednisolone is needed to produce immunosuppression. Proc Clin Dial Transplant Forum (1977) 0.76
Enhanced acute lung damage following corticosteroid treatment. Am Rev Respir Dis (1984) 0.76
Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012. Crit Care Med (2013) 39.56
Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock, 2012. Intensive Care Med (2013) 17.37
Hydrocortisone therapy for patients with septic shock. N Engl J Med (2008) 15.85
Clinical practice guidelines for the sustained use of sedatives and analgesics in the critically ill adult. Crit Care Med (2002) 9.74
Critical care medicine in the United States 2000-2005: an analysis of bed numbers, occupancy rates, payer mix, and costs. Crit Care Med (2010) 6.26
Bench-to-bedside review: Rhabdomyolysis -- an overview for clinicians. Crit Care (2004) 5.39
Recommendations for the diagnosis and management of corticosteroid insufficiency in critically ill adult patients: consensus statements from an international task force by the American College of Critical Care Medicine. Crit Care Med (2008) 5.30
Hypothalamic-pituitary-adrenal axis, neuroendocrine factors and stress. J Psychosom Res (2002) 4.93
Noncoding RNA gas5 is a growth arrest- and starvation-associated repressor of the glucocorticoid receptor. Sci Signal (2010) 4.77
Critical care medicine in the United States: addressing the intensivist shortage and image of the specialty. Crit Care Med (2013) 4.76
A prospective randomised multi-centre controlled trial on tight glucose control by intensive insulin therapy in adult intensive care units: the Glucontrol study. Intensive Care Med (2009) 4.13
Volume-limited versus pressure-limited hemodynamic management in septic and nonseptic shock. Crit Care Med (2012) 4.10
Insomnia with objective short sleep duration is associated with a high risk for hypertension. Sleep (2009) 4.01
Fluid resuscitation in sepsis: a systematic review and network meta-analysis. Ann Intern Med (2014) 3.96
Critical care medicine in the United States 1985-2000: an analysis of bed numbers, use, and costs. Crit Care Med (2004) 3.62
Corticosteroid treatment and intensive insulin therapy for septic shock in adults: a randomized controlled trial. JAMA (2010) 3.50
The effects of etomidate on adrenal responsiveness and mortality in patients with septic shock. Intensive Care Med (2009) 3.30
Death by parenteral nutrition. Intensive Care Med (2003) 3.25
Clinical practice guideline on diagnosis and treatment of hyponatraemia. Eur J Endocrinol (2014) 3.06
Combination chemotherapy in advanced adrenocortical carcinoma. N Engl J Med (2012) 2.82
Interactions of abiraterone, eplerenone, and prednisolone with wild-type and mutant androgen receptor: a rationale for increasing abiraterone exposure or combining with MDV3100. Cancer Res (2012) 2.81
Supine or sitting? Economic considerations regarding patient position during plasma metanephrine analysis for the exclusion of chromaffin tumours. Clin Endocrinol (Oxf) (2014) 2.67
Consensus statement on the use of gonadotropin-releasing hormone analogs in children. Pediatrics (2009) 2.67
Mutant P450 oxidoreductase causes disordered steroidogenesis with and without Antley-Bixler syndrome. Nat Genet (2004) 2.65
Stress hormones, proinflammatory and antiinflammatory cytokines, and autoimmunity. Ann N Y Acad Sci (2002) 2.51
Clinical and electrophysiological predictors of respiratory failure in Guillain-Barré syndrome: a prospective study. Lancet Neurol (2006) 2.50
TAC3/TACR3 mutations reveal preferential activation of gonadotropin-releasing hormone release by neurokinin B in neonatal life followed by reversal in adulthood. J Clin Endocrinol Metab (2010) 2.50
Has survival increased in cancer patients admitted to the ICU? Yes. Intensive Care Med (2014) 2.35
Practice parameters for hemodynamic support of sepsis in adult patients: 2004 update. Crit Care Med (2004) 2.33
ICU physicians should abandon the use of etomidate! Intensive Care Med (2005) 2.32
Clinical and biochemical consequences of CYP17A1 inhibition with abiraterone given with and without exogenous glucocorticoids in castrate men with advanced prostate cancer. J Clin Endocrinol Metab (2011) 2.32
Gene profiling reveals unknown enhancing and suppressive actions of glucocorticoids on immune cells. FASEB J (2002) 2.26
The paradoxical effect of obesity on outcome in critically ill patients. Crit Care Med (2006) 2.25
Outcome of acute mesenteric ischemia in the intensive care unit: a retrospective, multicenter study of 780 cases. Intensive Care Med (2015) 2.25
Aerobic exercise training improves insulin sensitivity without changes in body weight, body fat, adiponectin, and inflammatory markers in overweight and obese girls. Metabolism (2005) 2.24
Circulating vasopressin levels in septic shock. Crit Care Med (2003) 2.22
Screening for congenital hypothyroidism: the significance of threshold limit in false-negative results. J Clin Endocrinol Metab (2010) 2.20
Protocols: help for improvement but beware of regression to the mean and mediocrity. Intensive Care Med (2015) 2.15
Cytokine dysregulation, inflammation and well-being. Neuroimmunomodulation (2005) 2.15
Clinical practice guideline on diagnosis and treatment of hyponatraemia. Nephrol Dial Transplant (2014) 2.10
Sleep apnea is a manifestation of the metabolic syndrome. Sleep Med Rev (2005) 2.09
Guidelines for management of small bowel obstruction. J Trauma (2008) 2.05
Metabolic consequences of stress during childhood and adolescence. Metabolism (2011) 2.04
Practice management guidelines for selective nonoperative management of penetrating abdominal trauma. J Trauma (2010) 2.03
Sleep, the hypothalamic-pituitary-adrenal axis, and cytokines: multiple interactions and disturbances in sleep disorders. Endocrinol Metab Clin North Am (2002) 2.02
Pulsatile flow during cardiopulmonary bypass preserves postoperative microcirculatory perfusion irrespective of systemic hemodynamics. J Appl Physiol (1985) (2012) 2.00
Perceived Stress Scale: reliability and validity study in Greece. Int J Environ Res Public Health (2011) 1.99
Decompression sickness in urban divers in France. Int Marit Health (2012) 1.98
Puberty-related influences on brain development. Mol Cell Endocrinol (2006) 1.93
Immunotherapy for Guillain-Barré syndrome: a systematic review. Brain (2007) 1.87
Are religion and religiosity important to end-of-life decisions and patient autonomy in the ICU? The Ethicatt study. Intensive Care Med (2012) 1.80
Pulmonary complications of novel antineoplastic agents for solid tumors. Chest (2008) 1.80
Modest reversal of metabolic syndrome manifestations with vitamin D status correction: a 12-month prospective study. Metabolism (2011) 1.79
Pediatric stress: hormonal mediators and human development. Horm Res (2003) 1.79
How to avoid precipitating an acute adrenal crisis. BMJ (2012) 1.78
Major depression is associated with significant diurnal elevations in plasma interleukin-6 levels, a shift of its circadian rhythm, and loss of physiological complexity in its secretion: clinical implications. J Clin Endocrinol Metab (2005) 1.77
Increased vitamin D supplementation recommended during summer season in the gulf region: a counterintuitive seasonal effect in vitamin D levels in adult, overweight and obese Middle Eastern residents. Clin Endocrinol (Oxf) (2012) 1.77
Alkaline phosphatase for treatment of sepsis-induced acute kidney injury: a prospective randomized double-blind placebo-controlled trial. Crit Care (2012) 1.76
Diabetes mellitus type 2 and other chronic non-communicable diseases in the central region, Saudi Arabia (Riyadh cohort 2): a decade of an epidemic. BMC Med (2011) 1.76
Novel associations in disorders of sex development: findings from the I-DSD Registry. J Clin Endocrinol Metab (2013) 1.76
Tissue glucocorticoid resistance/hypersensitivity syndromes. J Steroid Biochem Mol Biol (2003) 1.74
Adrenal function in sepsis: the retrospective Corticus cohort study. Crit Care Med (2007) 1.74
Critical care medicine use and cost among Medicare beneficiaries 1995-2000: major discrepancies between two United States federal Medicare databases. Crit Care Med (2007) 1.73
Sepsis-associated delirium. Intensive Care Med (2007) 1.72
CHRONIC INSOMNIA AND STRESS SYSTEM. Sleep Med Clin (2007) 1.72
Anemia, allogenic blood transfusion, and immunomodulation in the critically ill. Chest (2005) 1.70
Brain lesions in septic shock: a magnetic resonance imaging study. Intensive Care Med (2007) 1.69
The human glucocorticoid receptor: molecular basis of biologic function. Steroids (2009) 1.69
Cyclin-dependent kinase 5 differentially regulates the transcriptional activity of the glucocorticoid receptor through phosphorylation: clinical implications for the nervous system response to glucocorticoids and stress. Mol Endocrinol (2007) 1.68
Nonclassic lipoid congenital adrenal hyperplasia masquerading as familial glucocorticoid deficiency. J Clin Endocrinol Metab (2009) 1.68
Genotype-phenotype analysis in congenital adrenal hyperplasia due to P450 oxidoreductase deficiency. J Clin Endocrinol Metab (2011) 1.67
Diabetic status and the relation of the three domains of glycemic control to mortality in critically ill patients: an international multicenter cohort study. Crit Care (2013) 1.66
Compartmentalization of the inflammatory response in sepsis and SIRS. J Endotoxin Res (2006) 1.66
Quantitative diagnosis of diffuse alveolar damage using extravascular lung water. Crit Care Med (2013) 1.64
Brugada electrocardiographic pattern in a postoperative patient. Crit Care Med (2005) 1.64
Gas chromatography/mass spectrometry (GC/MS) remains a pre-eminent discovery tool in clinical steroid investigations even in the era of fast liquid chromatography tandem mass spectrometry (LC/MS/MS). J Steroid Biochem Mol Biol (2010) 1.63
Cardiovascular response to dopamine and early prediction of outcome in septic shock: a prospective multiple-center study. Crit Care Med (2005) 1.63
Impaired nighttime sleep in healthy old versus young adults is associated with elevated plasma interleukin-6 and cortisol levels: physiologic and therapeutic implications. J Clin Endocrinol Metab (2003) 1.63
Stress, visceral obesity, and metabolic complications. Ann N Y Acad Sci (2006) 1.62
Multidisciplinary family meetings in the ICU facilitate end-of-life decision making. Am J Hosp Palliat Care (2009) 1.61
Outcome of Cushing's disease following transsphenoidal surgery in a single center over 20 years. J Clin Endocrinol Metab (2012) 1.61
Hyperandrogenemia predicts metabolic phenotype in polycystic ovary syndrome: the utility of serum androstenedione. J Clin Endocrinol Metab (2014) 1.61
A balanced view of balanced solutions. Crit Care (2010) 1.61
Guillain-Barré syndrome following primary cytomegalovirus infection: a prospective cohort study. Clin Infect Dis (2011) 1.60
Stress dose of hydrocortisone is not beneficial in patients with classic congenital adrenal hyperplasia undergoing short-term, high-intensity exercise. J Clin Endocrinol Metab (2004) 1.60
Interactions of the circadian CLOCK system and the HPA axis. Trends Endocrinol Metab (2010) 1.60
No evidence for hepatic conversion of dehydroepiandrosterone (DHEA) sulfate to DHEA: in vivo and in vitro studies. J Clin Endocrinol Metab (2005) 1.59
Brainstem responses can predict death and delirium in sedated patients in intensive care unit. Crit Care Med (2011) 1.59
Citrate anticoagulation versus systemic heparinisation in continuous venovenous hemofiltration in critically ill patients with acute kidney injury: a multi-center randomized clinical trial. Crit Care (2014) 1.59
Assessing adrenal insufficiency of corticosteroid secretion using free versus total cortisol levels in critical illness. Intensive Care Med (2011) 1.58
Genotype-phenotype correlation in 153 adult patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency: analysis of the United Kingdom Congenital adrenal Hyperplasia Adult Study Executive (CaHASE) cohort. J Clin Endocrinol Metab (2013) 1.58
Mutations in the genes encoding 11beta-hydroxysteroid dehydrogenase type 1 and hexose-6-phosphate dehydrogenase interact to cause cortisone reductase deficiency. Nat Genet (2003) 1.58